Physician profile
Brian Harlin
NPI 1609969500
$3,352.38
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $713 · 2020: $140 · 2021: $1,071 · 2022: $518 · 2023: $365 · 2024: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $909.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $667.16 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $619.46 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $376.81 | 2021-2022 | |
| Becton, Dickinson and Company | $248.09 | 2023-2024 | Phasix Mesh |
| Napo Pharmaceuticals INC | $248.04 | 2022 | |
| Romark Laboratories, Lc | $230.20 | 2019 | |
| Davol INC. | $206.91 | 2023 | Phasix Mesh |
| Qol Medical, LLC | $174.99 | 2021 | |
| Redhill Biopharma INC. | $150.00 | 2021 | |
| Celgene Corporation | $131.30 | 2019 | |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Ambu INC. | $49.66 | 2021 | |
| Laborie Medical Technologies Corp. | $37.55 | 2024 | Solar Uroflow System |
| Tela Bio, INC. | $30.43 | 2024 | Ovitex 2s |
| Axonics, INC. | $21.29 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $19.90 | 2019 | |
| Trevena, INC. | $15.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Harlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.